Thariat J, Pham T, Coupey J, Clarisse B, Grellard J, Rousseau N
BMC Cancer. 2024; 24(1):1230.
PMID: 39369231
PMC: 11453088.
DOI: 10.1186/s12885-024-13002-1.
Berrington de Gonzalez A, Gibson T, Lee C, Albert P, Griffin K, Kitahara C
Adv Radiat Oncol. 2023; 8(6):101273.
PMID: 38047226
PMC: 10692298.
DOI: 10.1016/j.adro.2023.101273.
Nuyts S, Bollen H, Ng S, Corry J, Eisbruch A, Mendenhall W
Cancers (Basel). 2022; 14(11).
PMID: 35681568
PMC: 9179360.
DOI: 10.3390/cancers14112587.
Burnet N, Mee T, Gaito S, Kirkby N, Aitkenhead A, Anandadas C
Br J Radiol. 2022; 95(1133):20211175.
PMID: 35220723
PMC: 10993980.
DOI: 10.1259/bjr.20211175.
Jongen A, Charlier F, Baker K, Chang J, Hartsell W, Laramore G
Adv Radiat Oncol. 2022; 7(1):100767.
PMID: 35071826
PMC: 8767257.
DOI: 10.1016/j.adro.2021.100767.
What men want: Results from a national survey on decision making for prostate cancer treatment and research participation.
Mendenhall N, Rausch Osian S, Bryant C, Hoppe B, Morris C
Clin Transl Sci. 2021; 14(6):2314-2326.
PMID: 34379363
PMC: 8604236.
DOI: 10.1111/cts.13090.
Current Situation of Proton Therapy for Hodgkin Lymphoma: From Expectations to Evidence.
Loap P, Mirandola A, De Marzi L, Dendale R, Iannalfi A, Vitolo V
Cancers (Basel). 2021; 13(15).
PMID: 34359647
PMC: 8345146.
DOI: 10.3390/cancers13153746.
Methodologies to Increase the Level of Evidence of Real-life Proton Therapy in Head and Neck Tumors.
Dionisi F, Widesott L, van Vulpen M, Fuller C, Frondizi R, Meneguzzo M
Int J Part Ther. 2021; 8(1):328-338.
PMID: 34285959
PMC: 8270108.
DOI: 10.14338/IJPT-20-00051.1.
Proton Therapy for Breast Cancer: A Consensus Statement From the Particle Therapy Cooperative Group Breast Cancer Subcommittee.
Mutter R, Choi J, Jimenez R, Kirova Y, Fagundes M, Haffty B
Int J Radiat Oncol Biol Phys. 2021; 111(2):337-359.
PMID: 34048815
PMC: 8416711.
DOI: 10.1016/j.ijrobp.2021.05.110.
The Reality of Randomized Controlled Trials for Assessing the Benefit of Proton Therapy: Critically Examining the Intent-to-Treat Principle in the Presence of Insurance Denial.
Hernandez M, Lee J, Yeap B, Ye R, Foote R, Busse P
Adv Radiat Oncol. 2021; 6(2):100635.
PMID: 33732960
PMC: 7940795.
DOI: 10.1016/j.adro.2020.100635.
Proton Therapy for Locally Advanced Oropharyngeal Cancer: Initial Clinical Experience at the University of Washington.
Aljabab S, Liu A, Wong T, Liao J, Laramore G, Parvathaneni U
Int J Part Ther. 2020; 6(3):1-12.
PMID: 32582809
PMC: 7038913.
DOI: 10.14338/IJPT-19-00053.1.
Perspectives on the model-based approach to proton therapy trials: A retrospective study of a lung cancer randomized trial.
McNamara A, Hall D, Shusharina N, Liu A, Wei X, Ajdari A
Radiother Oncol. 2020; 147:8-14.
PMID: 32224318
PMC: 7311259.
DOI: 10.1016/j.radonc.2020.02.022.
Technology-driven research for radiotherapy innovation.
Fiorino C, Guckemberger M, Schwarz M, van der Heide U, Heijmen B
Mol Oncol. 2020; 14(7):1500-1513.
PMID: 32124546
PMC: 7332218.
DOI: 10.1002/1878-0261.12659.
A 20-Year Analysis of Clinical Trials Involving Proton Beam Therapy.
Odei B, Boothe D, Keole S, Vargas C, Foote R, Schild S
Int J Part Ther. 2019; 3(3):398-406.
PMID: 31772989
PMC: 6871603.
DOI: 10.14338/IJPT-D-16-00030.1.
Systematic review of methodology used in clinical studies evaluating the benefits of proton beam therapy.
Ofuya M, McParland L, Murray L, Brown S, Sebag-Montefiore D, Hall E
Clin Transl Radiat Oncol. 2019; 19:17-26.
PMID: 31372521
PMC: 6660607.
DOI: 10.1016/j.ctro.2019.07.002.
An Update From the Pediatric Proton Consortium Registry.
Hess C, Indelicato D, Paulino A, Hartsell W, Hill-Kayser C, Perkins S
Front Oncol. 2018; 8:165.
PMID: 29881715
PMC: 5976731.
DOI: 10.3389/fonc.2018.00165.
[Proton therapy not superior to IMRT in locally advanced NSCLC].
Dutz A, Troost E, Lock S
Strahlenther Onkol. 2018; 194(8):790-793.
PMID: 29858611
DOI: 10.1007/s00066-018-1321-3.
Assessing the uncertainty in a normal tissue complication probability difference (∆NTCP): radiation-induced liver disease (RILD) in liver tumour patients treated with proton vs X-ray therapy.
Kobashi K, Prayongrat A, Kimoto T, Toramatsu C, Dekura Y, Katoh N
J Radiat Res. 2018; 59(suppl_1):i50-i57.
PMID: 29538699
PMC: 5868200.
DOI: 10.1093/jrr/rry018.
Present developments in reaching an international consensus for a model-based approach to particle beam therapy.
Prayongrat A, Umegaki K, van der Schaaf A, Koong A, Lin S, Whitaker T
J Radiat Res. 2018; 59(suppl_1):i72-i76.
PMID: 29529229
PMC: 5868183.
DOI: 10.1093/jrr/rry008.
Bayesian Adaptive Randomization Trial of Passive Scattering Proton Therapy and Intensity-Modulated Photon Radiotherapy for Locally Advanced Non-Small-Cell Lung Cancer.
Liao Z, Lee J, Komaki R, Gomez D, OReilly M, Fossella F
J Clin Oncol. 2018; 36(18):1813-1822.
PMID: 29293386
PMC: 6008104.
DOI: 10.1200/JCO.2017.74.0720.
